The University Of QueenslandDiamantina Institute - for Cancer, Immunology and Metabolic Medicine
The Diamantina Institute has now grown to include over 200 researchers, students and support staff. Headed by 2006 Australian of the Year, Professor Ian Frazer, the Institute leads the way in translational research into cancer, immunology and metabolic medicine.
Based at Brisbane’s leading teaching hospital, the Princess Alexandra Hospital, the Diamantina Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. Our researchers focus their efforts at turning their scientific discoveries into better treatments for diseases like cancer, diabetes, obesity, arthritis and osteoporosis.
The aim of our research is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients.
Our Research
The aim of our research at the Diamantina Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Translational research attempts to connect basic scientific research with real patient outcomes. Bringing our discoveries quickly to the aid of patients is central to our mission, and as a result we often have a number of clinical and research trials running concurrently to our lab-based research.
With over 200 researchers, students and support staff, our research activities are focused into three major areas:
|
